Navigation Links
Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
Date:7/28/2009

SAN FRANCISCO, July 28 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that it will hold a conference call on Tuesday, August 4, 2009 to discuss the Company's second quarter 2009 results and provide a corporate update. Jerry McMahon, Ph.D., chairman and chief executive officer, Ronald A. Martell, president and chief operating officer, Greg Weaver, senior vice president and chief financial officer and Robert De Jager, M.D., chief medical officer, will host the call beginning at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). A press release for the second quarter ended June 30, 2009, will be released after markets close on August 4.

To participate in the live call by telephone, please dial 888-515-2880 (United States) or 719-457-2652 (International). In addition, the live conference call is being Webcast and can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at http://www.poniard.com. A replay of the Webcast will be available on the Company's Web site for 10 days.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multip
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
2. Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
3. Poniard Pharmaceuticals Files Shelf Registration
4. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
5. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
6. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
7. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
8. Poniard Pharmaceuticals Reschedules Fourth Quarter and Fiscal 2008 Results Conference Call for Monday, March 16
9. Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Results Conference Call on March 12
10. Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer
11. Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...ony set to take over Sonic Foundrys desktop audio,...ic Foundry go from here? Two words: Mediasite Live...on video and audio conferencing market by enhancin...evicius, CEO of Sonic Foundry, said, "it is a grea...e there is no limit on new ideas for web conferenc...
...ny when, in February, the country,s largest HMO an...ith IBM to develop its own electronic medical reco...m -- and instead purchase packaged EMR software fr...ware developer (click here for more information)...lenge of supporting rollout of its EpicCare softwa...
...se organizations such as the Small Business Develo...e Wisconsin Women,s Business Initiative Corp. in M...for T.E.C. Incubator Center tenants and other area...ofit corporation providing management for the T.E....s a unique partnership between MATC and McAllen Pr...
Other Biology Technology:Sonic Foundry: What's Next? 2Kaiser On Schedule With Epic's Epic Project 2Kaiser On Schedule With Epic's Epic Project 3
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Einstein scientists link elevated insulin to increased breast cancer risk 51284 1Einstein scientists link elevated insulin to increased breast cancer risk 51284 2Deep Budget Cuts Will Add to Unemployment Rolls at Wrong Time 51282 1Deep Budget Cuts Will Add to Unemployment Rolls at Wrong Time 51282 2Deep Budget Cuts Will Add to Unemployment Rolls at Wrong Time 51282 3RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 1RealMed Receives 231 Ranking in the KLAS 2009 Ambulatory Clearinghouse Services Report 51279 2
...S, Iowa In Vikram Dalal,s 37 years of researching...ar cells for homes and buildings has improved from...s M. Whitney Professor of Electrical and Computer ...of the university,s Microelectronics Research Cent...h project could boost that efficiency to about 10 ...
...w study from the Centers for Disease Control and P...iated bloodstream infections caused by both methic...us . The 10-year national study, ,Methicillin-Resi...ted Bloodstream Infections in US Intensive Care Un...socomial Infection Surveillance (NNIS) and its suc...
..., N.Y. When a promising cancer drug reached clini...nted by the debilitating side effects that limited...s known as matrix metalloproteinases (MMPs). Now, ...ve shown that creating drugs that inactivate a dif...ity to target the tumor without the damaging side ...
Other Biology News:Iowa Power Fund advances researcher’s long quest for efficient solar power 2Iowa Power Fund advances researcher’s long quest for efficient solar power 3Press statement on new CDC MRSA study from SHEA president 2Researchers isolate protein domain linked to tumor progression 2
Rat Anti-Mouse P-Selectin / CD62P Monoclonal Antibody, Unconjugated, Clone 127933 from R&D Systems
Rat Leptin from Cell Sciences
Cat IgA ELISA Kit from Bethyl Laboratories
Cat IgM ELISA Kit from Bethyl Laboratories
Biology Products: